NIH-funded research NIH-funded research

New targeted therapy for cancer in veterans

Official title: Targeted nanoTherapy to Precision Oncology Platform (TnT POP) for Veterans

Funded at Jesse Brown VA Medical Center · NIH-10922028 · Data updated 2026-11-12

This study is exploring a new way to help veterans who are at higher risk for cancer because of toxin exposure, by using tiny particles that can target cancer cells and change their cholesterol levels to make treatments work better for tough-to-treat cancers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJesse Brown VA Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startOctober 1, 2024
Project endSeptember 30, 2028
Funding year2025
NIH project number1I01BX006541-01
Project IDNIH-10922028 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are veterans diagnosed with cancers that are resistant to standard treatments.

Less likely to help

Patients who do not have cancer or those with cancers that respond well to existing therapies may not benefit from this research.

What this research studies

This research focuses on developing a novel treatment approach for veterans who are at increased risk of cancer due to exposure to toxins. The team has discovered that certain cancers, particularly those resistant to traditional therapies like chemotherapy and radiation, share a common metabolic profile. By using specially engineered nanoparticles that target cancer cells, the research aims to improve treatment outcomes by effectively modulating cholesterol levels in these cells. This innovative approach could lead to more effective therapies for difficult-to-treat cancers.

Why it matters

Potential benefit: If successful, this research could provide a new, effective treatment option for veterans suffering from resistant cancers.

How similar studies have gone: While the approach of using engineered nanoparticles for cancer treatment is innovative, similar strategies have shown promise in other research, indicating potential for success.

Where this research is happening

  • Jesse Brown VA Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Thaxton, Colby Shad — Jesse Brown VA Medical Center
  • Study coordinator: Thaxton, Colby Shad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.